ICR | Vertex gearing up for launch as sickle cell therapy review advances

Vertex gearing up for launch as sickle cell therapy review advances

By early December, the Food and Drug Administration will decide on approval of a genetic medicine for sickle cell disease, potentially offering people with the rare blood condition a new, sought-after treatment option.

The oldest independent membership-led professional body for clinical researchers across the globe.